NSAIDs May Reduce GERD Subgroup’s Risk Of Esophageal Cancer – Lancet
This article was originally published in The Tan Sheet
Executive Summary
Individuals with Barrett's esophagus who did not take NSAIDs regularly had more than double the risk of esophageal cancer compared to regular users, according to an observational study published in the November issue of The Lancet Oncology
You may also be interested in...
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
FDA Tackles Observational Studies In Draft Health Claims Guidance
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: